Lasting Blood-Brain Barrier Disruption Induces Epileptic Focus in the Rat Somatosensory Cortex

Perturbations in the integrity of the blood-brain barrier have been reported in both humans and animals under numerous pathological conditions. Although the blood-brain barrier prevents the penetration of many blood constituents into the brain extracellular space, the effect of such perturbations on...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of neuroscience 2004-09, Vol.24 (36), p.7829-7836
Hauptverfasser: Seiffert, Ernst, Dreier, Jens P, Ivens, Sebastian, Bechmann, Ingo, Tomkins, Oren, Heinemann, Uwe, Friedman, Alon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7836
container_issue 36
container_start_page 7829
container_title The Journal of neuroscience
container_volume 24
creator Seiffert, Ernst
Dreier, Jens P
Ivens, Sebastian
Bechmann, Ingo
Tomkins, Oren
Heinemann, Uwe
Friedman, Alon
description Perturbations in the integrity of the blood-brain barrier have been reported in both humans and animals under numerous pathological conditions. Although the blood-brain barrier prevents the penetration of many blood constituents into the brain extracellular space, the effect of such perturbations on the brain function and their roles in the pathogenesis of cortical diseases are unknown. In this study we established a model for focal disruption of the blood-brain barrier in the rat cortex by direct application of bile salts. Exposure of the cerebral cortex in vivo to bile salts resulted in long-lasting extravasation of serum albumin to the brain extracellular space and was associated with a prominent activation of astrocytes with no inflammatory response or marked cell loss. Using electrophysiological recordings in brain slices we found that a focus of epileptiform discharges developed within 4-7 d after treatment and could be recorded up to 49 d postoperatively in >60% of slices from treated animals but only rarely (10%) in sham-operated controls. Epileptiform activity involved both glutamatergic and GABAergic neurotransmission. Epileptiform activity was also induced by direct cortical application of native serum, denatured serum, or albumin-containing solution. In contrast, perfusion with serum-adapted electrolyte solution did not induce abnormal activity, thereby suggesting that the exposure of the serum-devoid brain environment to serum proteins underlies epileptogenesis in the blood-brain barrier-disrupted cortex. Although many neuropathologies entail a compromised blood-brain barrier, this is the first direct evidence that it may have a role in the pathogenesis of focal cortical epilepsy, a common neurological disease.
doi_str_mv 10.1523/JNEUROSCI.1751-04.2004
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6729929</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17750928</sourcerecordid><originalsourceid>FETCH-LOGICAL-c592t-be3de7db9d1b82b4849d6e65c6ccbc7d0079ce1ee735311cccc6811332d6c3df3</originalsourceid><addsrcrecordid>eNpVkc1uEzEURi0EoqHwCpVXsJrgv7HHGyQSUgiKqNTSLZbHvkmMJuPUniH07XGUqIA3lnzP_fxJB6ErSqa0Zvz912-L-9ubu_lySlVNKyKmjBDxDE3KVFdMEPocTQhTpJJCiQv0KuefhBBFqHqJLmjNa0m1mKAfK5uH0G_wrIvRV7NkQ49nNqUACX8KOY37IcQeL3s_Osh4sQ8dlCeHr6MbMy70sAV8awd8F3d2iBn6HNMjnsc0wO_X6MXadhnenO9LdH-9-D7_Uq1uPi_nH1eVqzUbqha4B-Vb7WnbsFY0QnsJsnbSudYpX4prBxRA8ZpT6sqRDaWcMy8d92t-iT6ccvdjuwPvoB-S7cw-hZ1NjybaYP6f9GFrNvGXkYppzXQJeHsOSPFhhDyYXcgOus72EMdsqFI10awpoDyBLsWcE6yfPqHEHNWYJzXmqMYQYY5qyuLVvxX_rp1dFODdCdiGzfYQEpi8s11XcGoOhwMThkujmlL2DzALm7A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17750928</pqid></control><display><type>article</type><title>Lasting Blood-Brain Barrier Disruption Induces Epileptic Focus in the Rat Somatosensory Cortex</title><source>MEDLINE</source><source>PubMed Central(OpenAccess)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Seiffert, Ernst ; Dreier, Jens P ; Ivens, Sebastian ; Bechmann, Ingo ; Tomkins, Oren ; Heinemann, Uwe ; Friedman, Alon</creator><creatorcontrib>Seiffert, Ernst ; Dreier, Jens P ; Ivens, Sebastian ; Bechmann, Ingo ; Tomkins, Oren ; Heinemann, Uwe ; Friedman, Alon</creatorcontrib><description>Perturbations in the integrity of the blood-brain barrier have been reported in both humans and animals under numerous pathological conditions. Although the blood-brain barrier prevents the penetration of many blood constituents into the brain extracellular space, the effect of such perturbations on the brain function and their roles in the pathogenesis of cortical diseases are unknown. In this study we established a model for focal disruption of the blood-brain barrier in the rat cortex by direct application of bile salts. Exposure of the cerebral cortex in vivo to bile salts resulted in long-lasting extravasation of serum albumin to the brain extracellular space and was associated with a prominent activation of astrocytes with no inflammatory response or marked cell loss. Using electrophysiological recordings in brain slices we found that a focus of epileptiform discharges developed within 4-7 d after treatment and could be recorded up to 49 d postoperatively in &gt;60% of slices from treated animals but only rarely (10%) in sham-operated controls. Epileptiform activity involved both glutamatergic and GABAergic neurotransmission. Epileptiform activity was also induced by direct cortical application of native serum, denatured serum, or albumin-containing solution. In contrast, perfusion with serum-adapted electrolyte solution did not induce abnormal activity, thereby suggesting that the exposure of the serum-devoid brain environment to serum proteins underlies epileptogenesis in the blood-brain barrier-disrupted cortex. Although many neuropathologies entail a compromised blood-brain barrier, this is the first direct evidence that it may have a role in the pathogenesis of focal cortical epilepsy, a common neurological disease.</description><identifier>ISSN: 0270-6474</identifier><identifier>EISSN: 1529-2401</identifier><identifier>DOI: 10.1523/JNEUROSCI.1751-04.2004</identifier><identifier>PMID: 15356194</identifier><language>eng</language><publisher>United States: Soc Neuroscience</publisher><subject>2-Amino-5-phosphonovalerate - pharmacology ; 6-Cyano-7-nitroquinoxaline-2,3-dione - pharmacology ; Animals ; Bicuculline - pharmacology ; Bile Acids and Salts - toxicity ; Blood-Brain Barrier - drug effects ; Blood-Brain Barrier - physiology ; Coloring Agents - pharmacokinetics ; Dehydrocholic Acid - toxicity ; Deoxycholic Acid - toxicity ; Electrophysiology ; Epilepsies, Partial - chemically induced ; Epilepsies, Partial - physiopathology ; Evans Blue - pharmacokinetics ; Excitatory Amino Acid Antagonists - pharmacology ; gamma-Aminobutyric Acid - physiology ; Glutamic Acid - physiology ; Male ; Neurobiology of Disease ; Permeability ; Rats ; Rats, Wistar ; Receptors, AMPA - antagonists &amp; inhibitors ; Receptors, GABA - drug effects ; Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors ; Serum ; Serum Albumin - toxicity ; Somatosensory Cortex - physiopathology</subject><ispartof>The Journal of neuroscience, 2004-09, Vol.24 (36), p.7829-7836</ispartof><rights>Copyright © 2004 Society for Neuroscience 0270-6474/04/247829-08.00/0 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c592t-be3de7db9d1b82b4849d6e65c6ccbc7d0079ce1ee735311cccc6811332d6c3df3</citedby><cites>FETCH-LOGICAL-c592t-be3de7db9d1b82b4849d6e65c6ccbc7d0079ce1ee735311cccc6811332d6c3df3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6729929/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6729929/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15356194$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Seiffert, Ernst</creatorcontrib><creatorcontrib>Dreier, Jens P</creatorcontrib><creatorcontrib>Ivens, Sebastian</creatorcontrib><creatorcontrib>Bechmann, Ingo</creatorcontrib><creatorcontrib>Tomkins, Oren</creatorcontrib><creatorcontrib>Heinemann, Uwe</creatorcontrib><creatorcontrib>Friedman, Alon</creatorcontrib><title>Lasting Blood-Brain Barrier Disruption Induces Epileptic Focus in the Rat Somatosensory Cortex</title><title>The Journal of neuroscience</title><addtitle>J Neurosci</addtitle><description>Perturbations in the integrity of the blood-brain barrier have been reported in both humans and animals under numerous pathological conditions. Although the blood-brain barrier prevents the penetration of many blood constituents into the brain extracellular space, the effect of such perturbations on the brain function and their roles in the pathogenesis of cortical diseases are unknown. In this study we established a model for focal disruption of the blood-brain barrier in the rat cortex by direct application of bile salts. Exposure of the cerebral cortex in vivo to bile salts resulted in long-lasting extravasation of serum albumin to the brain extracellular space and was associated with a prominent activation of astrocytes with no inflammatory response or marked cell loss. Using electrophysiological recordings in brain slices we found that a focus of epileptiform discharges developed within 4-7 d after treatment and could be recorded up to 49 d postoperatively in &gt;60% of slices from treated animals but only rarely (10%) in sham-operated controls. Epileptiform activity involved both glutamatergic and GABAergic neurotransmission. Epileptiform activity was also induced by direct cortical application of native serum, denatured serum, or albumin-containing solution. In contrast, perfusion with serum-adapted electrolyte solution did not induce abnormal activity, thereby suggesting that the exposure of the serum-devoid brain environment to serum proteins underlies epileptogenesis in the blood-brain barrier-disrupted cortex. Although many neuropathologies entail a compromised blood-brain barrier, this is the first direct evidence that it may have a role in the pathogenesis of focal cortical epilepsy, a common neurological disease.</description><subject>2-Amino-5-phosphonovalerate - pharmacology</subject><subject>6-Cyano-7-nitroquinoxaline-2,3-dione - pharmacology</subject><subject>Animals</subject><subject>Bicuculline - pharmacology</subject><subject>Bile Acids and Salts - toxicity</subject><subject>Blood-Brain Barrier - drug effects</subject><subject>Blood-Brain Barrier - physiology</subject><subject>Coloring Agents - pharmacokinetics</subject><subject>Dehydrocholic Acid - toxicity</subject><subject>Deoxycholic Acid - toxicity</subject><subject>Electrophysiology</subject><subject>Epilepsies, Partial - chemically induced</subject><subject>Epilepsies, Partial - physiopathology</subject><subject>Evans Blue - pharmacokinetics</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>gamma-Aminobutyric Acid - physiology</subject><subject>Glutamic Acid - physiology</subject><subject>Male</subject><subject>Neurobiology of Disease</subject><subject>Permeability</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, AMPA - antagonists &amp; inhibitors</subject><subject>Receptors, GABA - drug effects</subject><subject>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</subject><subject>Serum</subject><subject>Serum Albumin - toxicity</subject><subject>Somatosensory Cortex - physiopathology</subject><issn>0270-6474</issn><issn>1529-2401</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkc1uEzEURi0EoqHwCpVXsJrgv7HHGyQSUgiKqNTSLZbHvkmMJuPUniH07XGUqIA3lnzP_fxJB6ErSqa0Zvz912-L-9ubu_lySlVNKyKmjBDxDE3KVFdMEPocTQhTpJJCiQv0KuefhBBFqHqJLmjNa0m1mKAfK5uH0G_wrIvRV7NkQ49nNqUACX8KOY37IcQeL3s_Osh4sQ8dlCeHr6MbMy70sAV8awd8F3d2iBn6HNMjnsc0wO_X6MXadhnenO9LdH-9-D7_Uq1uPi_nH1eVqzUbqha4B-Vb7WnbsFY0QnsJsnbSudYpX4prBxRA8ZpT6sqRDaWcMy8d92t-iT6ccvdjuwPvoB-S7cw-hZ1NjybaYP6f9GFrNvGXkYppzXQJeHsOSPFhhDyYXcgOus72EMdsqFI10awpoDyBLsWcE6yfPqHEHNWYJzXmqMYQYY5qyuLVvxX_rp1dFODdCdiGzfYQEpi8s11XcGoOhwMThkujmlL2DzALm7A</recordid><startdate>20040908</startdate><enddate>20040908</enddate><creator>Seiffert, Ernst</creator><creator>Dreier, Jens P</creator><creator>Ivens, Sebastian</creator><creator>Bechmann, Ingo</creator><creator>Tomkins, Oren</creator><creator>Heinemann, Uwe</creator><creator>Friedman, Alon</creator><general>Soc Neuroscience</general><general>Society for Neuroscience</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20040908</creationdate><title>Lasting Blood-Brain Barrier Disruption Induces Epileptic Focus in the Rat Somatosensory Cortex</title><author>Seiffert, Ernst ; Dreier, Jens P ; Ivens, Sebastian ; Bechmann, Ingo ; Tomkins, Oren ; Heinemann, Uwe ; Friedman, Alon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c592t-be3de7db9d1b82b4849d6e65c6ccbc7d0079ce1ee735311cccc6811332d6c3df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>2-Amino-5-phosphonovalerate - pharmacology</topic><topic>6-Cyano-7-nitroquinoxaline-2,3-dione - pharmacology</topic><topic>Animals</topic><topic>Bicuculline - pharmacology</topic><topic>Bile Acids and Salts - toxicity</topic><topic>Blood-Brain Barrier - drug effects</topic><topic>Blood-Brain Barrier - physiology</topic><topic>Coloring Agents - pharmacokinetics</topic><topic>Dehydrocholic Acid - toxicity</topic><topic>Deoxycholic Acid - toxicity</topic><topic>Electrophysiology</topic><topic>Epilepsies, Partial - chemically induced</topic><topic>Epilepsies, Partial - physiopathology</topic><topic>Evans Blue - pharmacokinetics</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>gamma-Aminobutyric Acid - physiology</topic><topic>Glutamic Acid - physiology</topic><topic>Male</topic><topic>Neurobiology of Disease</topic><topic>Permeability</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, AMPA - antagonists &amp; inhibitors</topic><topic>Receptors, GABA - drug effects</topic><topic>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</topic><topic>Serum</topic><topic>Serum Albumin - toxicity</topic><topic>Somatosensory Cortex - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seiffert, Ernst</creatorcontrib><creatorcontrib>Dreier, Jens P</creatorcontrib><creatorcontrib>Ivens, Sebastian</creatorcontrib><creatorcontrib>Bechmann, Ingo</creatorcontrib><creatorcontrib>Tomkins, Oren</creatorcontrib><creatorcontrib>Heinemann, Uwe</creatorcontrib><creatorcontrib>Friedman, Alon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seiffert, Ernst</au><au>Dreier, Jens P</au><au>Ivens, Sebastian</au><au>Bechmann, Ingo</au><au>Tomkins, Oren</au><au>Heinemann, Uwe</au><au>Friedman, Alon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lasting Blood-Brain Barrier Disruption Induces Epileptic Focus in the Rat Somatosensory Cortex</atitle><jtitle>The Journal of neuroscience</jtitle><addtitle>J Neurosci</addtitle><date>2004-09-08</date><risdate>2004</risdate><volume>24</volume><issue>36</issue><spage>7829</spage><epage>7836</epage><pages>7829-7836</pages><issn>0270-6474</issn><eissn>1529-2401</eissn><abstract>Perturbations in the integrity of the blood-brain barrier have been reported in both humans and animals under numerous pathological conditions. Although the blood-brain barrier prevents the penetration of many blood constituents into the brain extracellular space, the effect of such perturbations on the brain function and their roles in the pathogenesis of cortical diseases are unknown. In this study we established a model for focal disruption of the blood-brain barrier in the rat cortex by direct application of bile salts. Exposure of the cerebral cortex in vivo to bile salts resulted in long-lasting extravasation of serum albumin to the brain extracellular space and was associated with a prominent activation of astrocytes with no inflammatory response or marked cell loss. Using electrophysiological recordings in brain slices we found that a focus of epileptiform discharges developed within 4-7 d after treatment and could be recorded up to 49 d postoperatively in &gt;60% of slices from treated animals but only rarely (10%) in sham-operated controls. Epileptiform activity involved both glutamatergic and GABAergic neurotransmission. Epileptiform activity was also induced by direct cortical application of native serum, denatured serum, or albumin-containing solution. In contrast, perfusion with serum-adapted electrolyte solution did not induce abnormal activity, thereby suggesting that the exposure of the serum-devoid brain environment to serum proteins underlies epileptogenesis in the blood-brain barrier-disrupted cortex. Although many neuropathologies entail a compromised blood-brain barrier, this is the first direct evidence that it may have a role in the pathogenesis of focal cortical epilepsy, a common neurological disease.</abstract><cop>United States</cop><pub>Soc Neuroscience</pub><pmid>15356194</pmid><doi>10.1523/JNEUROSCI.1751-04.2004</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0270-6474
ispartof The Journal of neuroscience, 2004-09, Vol.24 (36), p.7829-7836
issn 0270-6474
1529-2401
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6729929
source MEDLINE; PubMed Central(OpenAccess); EZB-FREE-00999 freely available EZB journals
subjects 2-Amino-5-phosphonovalerate - pharmacology
6-Cyano-7-nitroquinoxaline-2,3-dione - pharmacology
Animals
Bicuculline - pharmacology
Bile Acids and Salts - toxicity
Blood-Brain Barrier - drug effects
Blood-Brain Barrier - physiology
Coloring Agents - pharmacokinetics
Dehydrocholic Acid - toxicity
Deoxycholic Acid - toxicity
Electrophysiology
Epilepsies, Partial - chemically induced
Epilepsies, Partial - physiopathology
Evans Blue - pharmacokinetics
Excitatory Amino Acid Antagonists - pharmacology
gamma-Aminobutyric Acid - physiology
Glutamic Acid - physiology
Male
Neurobiology of Disease
Permeability
Rats
Rats, Wistar
Receptors, AMPA - antagonists & inhibitors
Receptors, GABA - drug effects
Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors
Serum
Serum Albumin - toxicity
Somatosensory Cortex - physiopathology
title Lasting Blood-Brain Barrier Disruption Induces Epileptic Focus in the Rat Somatosensory Cortex
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T10%3A00%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lasting%20Blood-Brain%20Barrier%20Disruption%20Induces%20Epileptic%20Focus%20in%20the%20Rat%20Somatosensory%20Cortex&rft.jtitle=The%20Journal%20of%20neuroscience&rft.au=Seiffert,%20Ernst&rft.date=2004-09-08&rft.volume=24&rft.issue=36&rft.spage=7829&rft.epage=7836&rft.pages=7829-7836&rft.issn=0270-6474&rft.eissn=1529-2401&rft_id=info:doi/10.1523/JNEUROSCI.1751-04.2004&rft_dat=%3Cproquest_pubme%3E17750928%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17750928&rft_id=info:pmid/15356194&rfr_iscdi=true